---
title: "Lepu Biopharma names Ren Fangyuan employee representative supervisor, replacing Zhao Lixuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292736688.md"
description: "Lepu Biopharma has appointed Ren Fangyuan as employee representative supervisor, replacing Zhao Lixuan, effective July 15, 2026. Ren will serve for the remainder of the current supervisory board term. He joined the group in August 2025 as an officer in the Securities Business Department and holds degrees in Finance from Concordia University and the University of Rochester."
datetime: "2026-07-15T08:49:31.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292736688.md)
  - [en](https://longbridge.com/en/news/292736688.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292736688.md)
generator: "portal-rs"
---

# Lepu Biopharma names Ren Fangyuan employee representative supervisor, replacing Zhao Lixuan

-   Lepu Biopharma replaced employee representative supervisor Zhao Lixuan, effective July 15, 2026. \* Ren Fangyuan took the role for the remainder of the current supervisory board term. \* Ren joined the group in August 2025, serves as an officer in the Securities Business Department. \* Ren holds a BSc in Finance from Concordia University, MSc in Finance from the University of Rochester. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lepu Biopharma Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260715-12244806), on July 15, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [02157.HK](https://longbridge.com/en/quote/02157.HK.md)
- [00388.HK](https://longbridge.com/en/quote/00388.HK.md)
- [80388.HK](https://longbridge.com/en/quote/80388.HK.md)
- [HKXCY.US](https://longbridge.com/en/quote/HKXCY.US.md)

## Related News & Research

- [Lepu Biopharma says Phase III CLARITY-Gastric01 trial meets overall survival endpoint for CMG901 in late-line gastric cancer](https://longbridge.com/en/news/294009343.md)
- [Lepu Biopharma FY26 H1 profit falls 15.2% to RMB 24.8 million; revenue rises 12.1% to RMB 522.4 million](https://longbridge.com/en/news/296324965.md)
- [China Sandi appoints Wong Mei as company secretary after Poon resignation](https://longbridge.com/en/news/296503443.md)
- [David Sacks Says the Biggest Risk to the AI Buildout Isn’t Demand, ‘If You Had Dark GPUs, That’d Be a Disaster for Everyone’](https://longbridge.com/en/news/296382233.md)
- [Lehto Group appoints Janne Lehto CFO effective September 2026](https://longbridge.com/en/news/296437241.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**